Atlas Trials

Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration

Clinical trial NCT07221656 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07221656
Sponsor
Mayo Clinic
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Childhood Acute Lymphoblastic LeukemiaChildhood Lymphoblastic Lymphoma
Start date
2027-02-01
Primary completion
2028-12-31
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.